DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin Hydrochloride) - Current Clinical Trials


Epirubicin Related Clinical Trials

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer [Terminated]

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors [Completed]

Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer [Active, not recruiting]

Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer [Recruiting]

Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer [Completed]

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer [Completed]

Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer [Completed]

Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) [Completed]

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer [Recruiting]

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 [Active, not recruiting]

Phase I Combination w/ Epirubicin [Completed]

Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer [Completed]

Docetaxel and Epirubicin in Advanced Gastric Cancer [Completed]

A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer [Completed]

Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies [Completed]

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer [Recruiting]

Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer [Completed]

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility [Completed]

Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer [Completed]

Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer [Active, not recruiting]

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer [Terminated]

Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer [Recruiting]

Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer [Completed]

A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients [Recruiting]

The Study of Irinotecan Plus Epirubicin as the Second-line Chemoregime for Advanced Gastric Cancer [Not yet recruiting]

Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer [Terminated]

Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients [Completed]

Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors [Terminated]

Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer [Completed]

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer [Completed]

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer [Completed]

Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC) [Completed]

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma [Active, not recruiting]

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma [Completed]

A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early [Active, not recruiting]

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer [Recruiting]

Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma [Completed]

Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO) [Completed]

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer [Active, not recruiting]

Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer [Completed]

A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 Study [Completed]

Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer [Completed]

Study of Epirubicin (PharmorubicinŽ), Carboplatin (ParaplatinŽ) and Capecitabine (XelodaŽ) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [Terminated]

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma [Completed]

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors [Active, not recruiting]

Early Cardiac Toxicity of Adjuvant CT in Elderly BC. [Terminated]

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer [Completed]

Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer [Active, not recruiting]

A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer [Completed]

REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer [Terminated]

Phase II Trial for Large ER-Negative Breast Cancers [Active, not recruiting]

Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach [Active, not recruiting]

Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer [Completed]

Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer [Recruiting]

Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel [Completed]

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer [Active, not recruiting]

Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC) [Completed]

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer [Completed]

Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma [Terminated]

Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors [Completed]

A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer [Not yet recruiting]

Epirubicin and Thalidomide in Treating Patients With Liver Cancer [Completed]

A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. [Completed]

Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer [Recruiting]

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer [Completed]

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Completed]

Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer [Withdrawn]

A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin [Recruiting]

Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer [Completed]

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer [Completed]

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer [Completed]

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer [Completed]

Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer [Completed]

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer [Completed]

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 [Active, not recruiting]

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma [Recruiting]

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients [Completed]

Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer [Completed]

Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer [Not yet recruiting]

High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II [Completed]

Molecular Triaging of Newly Diagnosed Breast Cancer [Withdrawn]

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer [Recruiting]

EC (Epirubicin, Cyclophosphamide) Followed by T (Docetaxel) Versus ET (Epirubicin, Docetaxel) Followed by X (Capecitabine) as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Patients [Completed]

Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm [Recruiting]

A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer [Completed]

The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients [Recruiting]

Phase II Neoadjuvant in Inflammatory Breast Cancer [Terminated]

Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder [Completed]

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer [Recruiting]

Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma [Recruiting]

A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients [Recruiting]

Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer [Not yet recruiting]

Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer [Terminated]

Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer [Recruiting]

Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach [Active, not recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017